Sharechat Logo

Genesis appoints new ceo

Tuesday 5th August 2003

Text too small?
Genesis Research and Development Corporation Limited has appointed Dr Peter Lee, an expatriate New Zealander, as chief executive of AgriGenesis Biosciences Ltd, its plant science subsidiary.

"Dr Lee has an impressive track record in management and commercialisation of research," Genesis chief executive Dr Jim Watson says. "He also has an excellent network of contacts, having held senior positions in the North American forest and paper products industry for over 25 years."

Dr Lee completed a PhD in chemical and materials engineering at Auckland University and has worked for leading US forest and paper products companies since then. Most recently he has been vice president, Global Research and Development for Carter Holt Harvey's parent company International Paper, where he was responsible for research management, technology collaborations and commercialisation of new products. He has also held senior positions with Mead Paper Company and Weyerhaeuser Company.

Dr Lee has had extensive experience in developing innovative products and production technologies. He has expertise in strategic planning, innovation and internal ventures, and securing capital investments as well as managing research and product development.

Dr Lee will report directly to the Genesis board. Dr Watson will continue as chief executive of Genesis Research and will also resume responsibility as Head of the Health Division following the completion of Dr Doug Williams' term in New Zealand.

The establishment of AgriGenesis is expected to be completed by September.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Genesis Research directors quit due to lack of funds & communication
Genesis Research has ‘lack of funds’, seeks legal advice on future
Genesis Research halted from trading pending statement
Genesis Research calls off proposed merger with Mariposa Health
Kupe earnings bolster Genesis 1H profit by 125%
Genesis Research plans "reverse takeover"
Genesis Research director Graham Chin resigns in wake of rift with UBNZ
Tekapo purchase knocks $73m off Genesis bottom line
UBNZ gets in deeper with Genesis Research
Genesis Energy beats forecast